Related by context. All words. (Click for frequent words.) 74 CABP 71 acute bacterial exacerbations 68 pneumonia CAP 67 acute bacterial sinusitis 66 biodefense pathogens 64 Clostridium difficile associated 63 refractory gout 62 methicillin resistant S. aureus 62 cSSSI 62 BENLYSTA TM 61 toenail onychomycosis 61 faropenem medoxomil 61 nosocomial pneumonia 61 diarrhea CDAD 60 ketolide antibiotic 60 formerly LymphoStat B 60 cIAI 59 rheumatoid arthritis psoriatic arthritis 59 herpes zoster shingles 59 oropharyngeal candidiasis OPC 59 complicated intra abdominal 59 hepatitis C HCV 59 bronchitis sinusitis 58 ceftaroline 58 hypereosinophilic syndrome 58 indinavir Crixivan 58 Noxafil 58 acute onset CINV 58 acquired pneumonia HAP 58 disease CDAD 58 Acute Bacterial Sinusitis ABS 58 cSSSIs 58 Unit Dose Budesonide 58 chronic HCV infection 58 systemic lupus erythematosus psoriasis 58 cutaneous T 58 chronic bronchitis AECB 58 BENLYSTA ® 57 reslizumab 57 oral prodrug 57 Idiopathic Pulmonary Fibrosis IPF 57 CA MRSA infections 57 oxypurinol 57 structure infections ABSSSI 57 infections cIAI 57 pediatric Crohn disease 57 vitreoretinal disorders 57 ABSSSI 57 opioid induced constipation 57 SinuNase TM 57 LymphoStat B belimumab 57 AA amyloidosis 57 Restanza 57 Associated Methicillin Resistant 57 systemic juvenile idiopathic 57 diarrhea predominant irritable 57 invasive candidiasis 57 intra abdominal infections 56 vaginal candidiasis 56 onychomycosis 56 idiopathic pulmonary fibrosis IPF 56 oral antibiotic 56 psoriasis rheumatoid arthritis 56 dasatinib Sprycel ® 56 oral candidiasis 56 Cloretazine 56 Staphylococcus aureus bloodstream infections 56 generation oxazolidinone 56 FACTIVE R gemifloxacin 56 Kuvan R 56 candidemia 56 chronic plaque psoriasis 56 post herpetic neuralgia PHN 56 IMiDs ® 56 expanded autologous cellular 56 virus HCV infection 56 non alcoholic steatohepatitis 56 severe plaque psoriasis 56 constipation OIC 56 structure infections cSSSI 56 Acute Myeloid Leukemia AML 56 pseudobulbar affect PBA 56 SinuNase ™ 56 Telavancin 56 purpura ITP 56 Altastaph 56 Peginterferon alfa 2b 56 mixed dyslipidemia 56 CDAD Clostridium difficile 56 Pulmonary Arterial Hypertension PAH 56 delayed onset CINV 56 AA Amyloidosis 56 personalized cellular immunotherapy 56 SPRYCEL ® 56 Staphylococcus aureus S. aureus 56 INVANZ 56 esophageal candidiasis 56 post herpetic neuralgia 56 anti botulism antibody 56 Complicated Skin 56 gastrointestinal disorders characterized 56 injectable antibiotic 56 essential thrombocythemia ET 56 immunocompromised patients 56 cardiometabolic diseases 55 sapropterin dihydrochloride 55 constipation IBS C 55 Pseudomonas aeruginosa infections 55 sorafenib tablets 55 congenital ichthyosis 55 hepatitis B HBV 55 Streptococcus pneumoniae Haemophilus influenzae 55 Solzira ™ 55 nasal decolonization 55 necrotizing pancreatitis 55 oritavancin 55 dextromethorphan quinidine 55 MKC# MT 55 mesylate tablets 55 Raptiva R 55 Aryplase 55 antibiotic resistant bacterial infections 55 forodesine 55 cardio renal 55 HuLuc# 55 Pafuramidine 55 dyskinesia PD LID 55 Ribavirin causes 55 Ceftaroline 55 Idiopathic Pulmonary Fibrosis 55 Roche PEGASYS R 55 ceftazidime 55 right sided endocarditis 55 immunocompetent patients 55 topical anti infective 55 mesylate tablets approved 55 Friedreich Ataxia FRDA 55 rheumatoid arthritis Crohn disease 55 Promedior 55 CYT# potent vascular disrupting 55 including thyroiditis RA 55 Kit CD# positive 55 lintuzumab SGN 55 delayed CINV 55 Evoltra ® 55 oral Factor Xa 55 investigational monoclonal antibody 55 Gram positive 55 neuropathic pain metabolic diseases 55 acyclovir Lauriad R 55 nebulized budesonide 55 TPI ASM8 55 long acting muscarinic 55 sapropterin dihydrochloride Tablets 55 severe malignant osteopetrosis 55 Cethromycin 55 Arcalyst 55 liver cancers TTR 55 Cloderm ® Cream 55 microorganisms Staphylococcus aureus 55 prokinetic agent 55 daptomycin 55 ARCALYST 55 investigational antibiotic 55 Faropenem 55 kidney urologic 55 infectious diseases autoimmune diseases 55 Syndrome RLS 55 COPEGUS R 55 Amgen Neulasta R 55 treat chronic sinusitis 55 Fibrillex TM 55 invasive fungal infections 55 VIBATIV TM 55 OHR/AVR# 55 Syncria albiglutide 55 macrolide 55 Myocet 55 moxifloxacin HCl 55 cethromycin 54 aztreonam 54 Beyond Advair 54 psoriasis psoriatic arthritis 54 fluoroquinolone antibiotic 54 multi kinase inhibitor 54 Liprotamase 54 GW# [003] 54 Escherichia coli Klebsiella pneumoniae 54 candidate XP# 54 IMiDs R 54 tigecycline 54 Vitrasert ® 54 posaconazole 54 staphylococcal infections 54 apricitabine ATC 54 bacterial exacerbation 54 rheumatoid arthritis juvenile idiopathic 54 cell lymphoma CTCL 54 neurogenic orthostatic hypotension 54 Systemic Juvenile Idiopathic 54 injectable investigational 54 evaluating tivozanib 54 CDP# 54 faropenem 54 CTAP# Capsules 54 hematological malignancy 54 overactive bladder AA# 54 Plicera 54 Myelodysplastic Syndrome MDS 54 methylnaltrexone bromide 54 rasagiline tablets 54 S. aureus bloodstream infections 54 LymphoStat B TM 54 BENLYSTA belimumab 54 PRTX 54 HCV polymerase inhibitors 54 TTR amyloidosis 54 eosinophilic asthma 54 Ceflatonin R 54 rilonacept 54 Pegasys ® 54 hematologic disorders 54 IMiDs ® compound 54 BCR ABL inhibitor 54 Hereditary angioedema HAE 54 targeted radiotherapeutic 54 Teflaro 54 herpetic keratitis 54 Respiratory syncytial virus RSV 54 Enterococcus faecium 54 dihydrochloride Tablets 54 delivers fluocinolone acetonide FA 54 Streptococcus pyogenes 54 thrombolytic agent 54 CTAP# 54 familial amyloidotic polyneuropathy FAP 54 targeting Inflammatory Bowel 54 memantine HCl 54 chronic eosinophilic leukemia 54 broad spectrum cephalosporin 54 chronic hepatitis C. 54 PRT# 54 PD LID 54 dihydrochloride 54 refractory chronic lymphocytic 54 Acute Bacterial Skin 54 Viread tenofovir disoproxil fumarate 54 Xcytrin R 54 penicillin resistant Streptococcus 54 Acetavance TM intravenous acetaminophen 54 Wafer polifeprosan 54 inflammatory autoimmune 54 Tofacitinib 54 Lupus nephritis 54 included exfoliative dermatitis 54 Prodarsan R 54 Panzem R 54 Lambert Eaton Myasthenic 54 REMOXY ® 54 VISICOL R 54 recurrent genital herpes 54 Aerosurf 54 Aganocide 54 XIAFLEX ™ 54 uncomplicated urinary tract infections 54 Belimumab 54 induced mucositis 54 rhIGF-I/rhIGFBP-3 54 MPS VI 54 Milnacipran 54 immunomodulating 54 bacterial respiratory infections 54 TNFerade ™ 54 atherothrombotic events 54 oncolytic virus therapies 54 R sorafenib tablets 54 Systemic Sclerosis 54 respiratory tract infections 54 L Annamycin 54 advanced metastatic renal 54 NOXAFIL 54 pseudomembranous colitis 54 Adagen ® 53 inhalation powder 53 Ception Therapeutics 53 Selzentry Celsentri 53 human rhinovirus HRV 53 systemic fungal infections 53 evaluating picoplatin 53 DIFICID ™ 53 Nexavar ® 53 cognitive impairment associated 53 terlipressin 53 treat opioid induced 53 IMA# 53 receptor tyrosine kinase inhibitor 53 Aurexis R 53 ALN PCS 53 Quinamed 53 Skin Structure Infections ABSSSI 53 relapsed leukemia 53 itraconazole Sporanox 53 primary Restless Legs 53 posterior uveitis 53 Rituxan rituximab 53 Nonalcoholic fatty liver 53 Valopicitabine 53 systemic sclerosis SSc 53 rALLy clinical trial 53 subcutaneous formulation 53 cutaneous T cell 53 REMICADE ® 53 CCR9 antagonist 53 lucinactant 53 Thiovir 53 ocular infections 53 Teriflunomide 53 Kepivance 53 non metastatic osteosarcoma 53 efalizumab 53 Omacetaxine 53 immuno inflammatory diseases 53 phenylalanine ammonia lyase 53 debilitating complication 53 Cinryze ™ 53 secondary hyperparathyroidism 53 benign prostatic hypertrophy BPH 53 myeloproliferative neoplasms 53 cystic fibrosis bronchiectasis 53 Candida infection 53 Chronic HCV infection 53 SHPT 53 MOVIPREP R 53 chemotherapy induced neutropenia 53 albiglutide 53 Recombinant interferon alpha 53 containing granisetron 53 ZADAXIN ® 53 oral beclomethasone dipropionate 53 hemorrhagic fever viruses 53 Proquin XR 53 Onglyza saxagliptin 53 Sebivo 53 Candida infections 53 progressive psoriatic arthritis 53 markets COLAZAL 53 Phase IIb Trial 53 vosaroxin 53 DAS# [001] 53 bacteremic pneumonia 53 hypersensitivity reaction 53 Frozen Shoulder syndrome Adhesive 53 dermatological disorders 53 acetonide FA 53 candidiasis 53 Syndrome LEMS 53 MKC# MKC# PP 53 Chronic lymphocytic leukemia 53 pan histone deacetylase 53 Esbriet ® 53 TNF Tumor Necrosis Factor 53 Benlysta belimumab 53 idiopathic thrombocytopenic purpura ITP 53 atypical Hemolytic Uremic Syndrome 53 Shigatoxin producing E. coli 53 resistant Staphylococcus aureus MRSA 53 Systemic lupus erythematosus SLE 53 cirrhosis liver failure 53 Toctino ® alitretinoin 53 ara C 53 immunodeficiency disorders 53 oral antifungal 53 myelodysplastic myeloproliferative diseases 53 Hospital Acquired Pneumonia 53 alpha interferons 53 Shigamabs ® 53 Gastrointestinal Liner 53 BioNumerik 53 fluoroquinolone class 53 myocardial infarction ventricular fibrillation 53 unresectable liver cancer 53 virus HCV protease inhibitor 53 diabetic gastroparesis 53 Alinia 53 carcinoid syndrome 53 mild vasodilator 53 Amgen Neulasta ® 53 HCV RNA polymerase 53 lomitapide 53 Parkinson disease levodopa induced 53 TYGACIL 53 Oral NKTR 53 leading oral taxane 53 HeFH 53 PNP inhibitor 53 buccal tablets 53 vapreotide acetate 53 Initiates Phase II 53 pan HDAC inhibitor 53 debilitating autoimmune 53 systemic autoimmune 53 diarrhea fatigue asthenia 53 Vaprisol 53 chronic immune thrombocytopenic 53 cephalosporin antibiotic 53 Begins Dosing 53 Systemic Lupus Erythematosus SLE 53 Tezampanel 53 metformin HCl 53 Cryptococcus neoformans 53 evaluating pirfenidone 53 hepatic encephalopathy 53 ophthalmology oncology 53 antibody MAb 53 Auxilium transmucosal film 53 non nucleoside inhibitor 53 orphan medicinal product 53 baminercept 53 thiazolides 53 forodesine HCl 53 docetaxel Taxotere R 53 nephropathic cystinosis 53 Fodosine 53 TYZEKA 53 temsirolimus Torisel 53 Clolar ® 53 intranasal insulin product 53 Initiates Clinical Trial 53 FRAGMIN 53 drug pipeline TAFA# 53 arthritis PsA 53 novel antibody therapeutics 53 Actemra tocilizumab 53 steroid refractory ulcerative 53 riociguat 53 PROLOR Biotech Inc. 53 STELARA TM 53 AVAPRO 52 Tesetaxel 52 NXL# 52 aripiprazole Abilify 52 Atopic dermatitis 52 ATTR PN 52 Bicifadine 52 active ankylosing spondylitis 52 pouchitis 52 INSPIRE Trial Phase III 52 bacteremia 52 biodefense countermeasure 52 Phenoptin 52 abatacept Orencia 52 Anturol 52 progressive PsA 52 enhance ApoA 52 PEGylated Fab fragment 52 Methylnaltrexone 52 P#X# antagonist 52 Pegylated interferon 52 Xyfid TM 52 ACTEMRA TM 52 dipropionate 52 Skin Structure Infections 52 systemic lupus erythematosus SLE 52 docetaxel Taxotere ® 52 Crofelemer budesonide foam 52 Cetrorelix 52 Cerebril TM 52 AzaSite Plus ™ 52 R PEG uricase 52 oral antiviral 52 polymerase inhibitors 52 stable angina pectoris 52 HQK 52 BYETTA ® 52 neuroendocrine cancers 52 Anidulafungin 52 Archexin 52 cutaneous lupus 52 unknown etiology 52 zidovudine AZT 52 severe hepatomegaly 52 DORIBAX 52 humanized therapeutic 52 sodium stibogluconate 52 acute angioedema 52 infliximab Remicade 52 JZP 52 ocrelizumab 52 oncologic diseases 52 6R BH4 52 autoantibody positive 52 nucleotide analog 52 pancreatic enzyme replacement 52 Disease IBD 52 Aztreonam lysine 52 erlotinib Tarceva R 52 Amigal 52 Zalypsis 52 leukemia AML 52 commercializes innovative biopharmaceuticals 52 leukotriene pathway 52 SIMPONI TM 52 HCV protease inhibitor 52 imatinib Gleevec ® 52 Phase 2b Trial 52 heterozygous FH 52 myelofibrosis polycythemia vera 52 pulmonary hypertension PH 52 AzaSite Plus 52 human C1 inhibitor 52 surgical cryoablation 52 CDAD 52 iobenguane 52 Personalized Immunotherapy 52 secondary hyperparathyroidism SHPT 52 methicillin susceptible 52 3 kinase PI3K 52 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 52 PHX# 52 Mucositis 52 ciprofloxacin hydrochloride 52 Pegloticase 52 beta lactamase inhibitor 52 novel bactericidal 52 albinterferon alfa 2b 52 alvespimycin 52 Mycamine 52 indolent NHL 52 Alvine Pharmaceuticals 52 postherpetic neuralgia PHN 52 Uricase PEG 52 Solulin 52 fluconazole resistant 52 rheumatoid arthritis Roche PEGASYS 52 FTY# fingolimod 52 DIRECT Trial 52 AN# novel 52 pancreatic insufficiency 52 Neutrolin ® 52 BiovaxID TM 52 Primaxin 52 Prulifloxacin 52 mediated amyloidosis ATTR hypercholesterolemia 52 arsenic trioxide injection 52 acting muscarinic antagonist 52 REPRONEX R menotropins 52 hour bronchodilation 52 delta gamma agonist 52 Balamuthia 52 AAG geldanamycin analog 52 non constipation irritable 52 Lubiprostone 52 Lenocta TM 52 Sudhir Agrawal D.Phil 52 Zorbtive TM 52 tyrosine kinase inhibitors TKIs 52 intranasal formulation 52 polyneuropathy HIV DSP 52 nanofiltered plasma derived 52 AEG# 52 Zenvia ™ 52 DU #b 52 Perforomist ™ Inhalation Solution 52 KETEK 52 Arno Therapeutics 52 fistulizing CD 52 thetreatment 52 rheumatoid arthritis psoriasis 52 marketed pegylated interferons 52 Intravenous Human 52 haematological malignancies 52 inhaled liposomal ciprofloxacin 52 gastrointestinal mucositis 52 diabetic macular edema DME 52 FACTIVE ® 52 factor TNF receptor 52 non peptidic protease 52 cSSTI 52 castrate resistant prostate cancer 52 chronic constipation CC 52 Inhalation Aerosol 52 lenalidomide Revlimid R 52 Chronic hepatitis C 52 cidofovir 52 LEVADEX TM 52 registrational trials 52 Iluvien ® 52 Adalimumab 52 markets Gelclair R 52 relapsed refractory AML 52 TELINTRA 52 fibrosis IPF 52 Lixivaptan 52 MCSP respectively 52 absorbable powder hemostat 52 alefacept 52 Thrombin topical Recombinant 52 Solzira TM 52 multiple myeloma MM 52 brand ciclesonide HFA 52 Vitrasert R 52 severe hypercholesterolemia 52 JAK inhibitors 52 PEGINTRON TM 52 skeletal muscle weakness 52 Phase IIb trials 52 psoriasis Crohn disease 52 DOR# 52 SNT-MC#/idebenone 52 treat lupus renal 52 amphotericin B 52 Factor VIIa 52 gastro intestinal inflammation 52 NYHA Class II 52 EnzymeRx 52 Nitazoxanide 52 lupus nephritis 52 dilated cardiomyopathy DCM 52 FOLOTYN ® 52 liver cancers hypercholesterolemia 52 painful diabetic neuropathy 52 SCH # 52 PDX pralatrexate 52 RhuDex ® 52 CCX# B 52 AFREZZA TM 52 GSK '# 52 adalimumab Humira 52 Vaccine Recombinant 52 ocular formulation 52 IBS C 52 Mylan Receives Approval 52 infectious diseases autoimmune 52 interstitial nephritis 52 Cimzia TM 52 virus HCV 52 Interferon Beta 52 EPIVIR 52 inhibitor PPI 52 TNFerade TM 52 Systemic lupus erythematosus 51 Veronate R 51 hyperphosphatemia 51 GlycoPEGylated hemostasis compounds 51 TBC# 51 azoles 51 Icatibant 51 migraine headaches AZ 51 Annamycin 51 soluble tumor necrosis 51 phenylketonuria PKU developed 51 RAPTIVA 51 antibacterial therapeutics 51 vWD 51 Infusion Reactions Severe 51 Aztreonam Lysine 51 angioedema 51 multicenter Phase III 51 Dalbavancin 51 investigational compounds 51 C1 esterase inhibitor 51 JNJ Q2 51 interferon beta 1a infertility 51 ruboxistaurin 51 Traficet EN 51 Aviptadil 51 C1 inhibitor deficiency 51 NP2 Enkephalin 51 molecular imaging radiopharmaceutical 51 interferon alfacon 1 51 Solesta TM 51 DPP4 inhibitor 51 sapacitabine CYC# 51 Phase Ib clinical trials 51 StaphVAX R 51 PMX # PolyMedix 51 Nasdaq ALTH 51 Ostabolin C 51 Nivestim 51 OMNARIS HFA 51 AZILECT ® 51 diabetic neuropathic pain 51 prescribed proton pump 51 rheumatoid arthritis thrombocytopenia 51 R metformin Concor 51 cutaneous manifestations 51 phenylketonuria PKU 51 voriconazole 51 chronic hepatitis C 51 neutropenia dehydration dyspnea 51 BRIM2 51 transplantation HCT 51 hyperphenylalaninemia HPA due 51 PEGylated anti 51 Dementia Related Psychosis 51 Ostabolin C TM 51 tumor lysis syndrome 51 erythematosus 51 fatal hemorrhagic 51 renal failure interstitial lung 51 Tygacil 51 neurological manifestations 51 varicella zoster virus VZV 51 generation purine nucleoside 51 Vandetanib 51 candidate Puricase 51 hematological diseases 51 topically applied SEPA 51 chronic myocardial ischemia 51 MPS IVA 51 Piperacillin 51 transfusional iron overload 51 anti MRSA cephalosporin 51 RSR# 51 dependent kinase inhibitor 51 Postherpetic neuralgia PHN 51 hyaluronidase enzyme 51 AVONEX ® 51 severe hypersensitivity reactions 51 delafloxacin 51 rheumatoid arthritis osteoarthritis ankylosing 51 Navelbine ® 51 diabetic peripheral neuropathic pain 51 anti infective treatments 51 sodium Injection 51 diarrhea vomiting rash 51 ACHN 51 Orphan Medicinal Product 51 ALV# 51 methicillin susceptible Staphylococcus aureus 51 K. pneumoniae 51 investigational humanized monoclonal antibody 51 Synergy Pharmaceuticals 51 inflammatory autoimmune diseases 51 antagonist LAMA 51 selective modulator 51 LUVENIQ 51 radezolid 51 include PLX IBD 51 Romiplostim 51 rheumatoid arthritis inflammatory bowel 51 Solazed TM 51 albiglutide currently 51 candidate REP# 51 Alpha interferons including 51 infection sinusitis 51 oral dual endothelin 51 pheochromocytoma 51 Entest BioMedical Inc. 51 vascular occlusive diseases 51 Zalbin 51 Myelofibrosis 51 Hepatitis B reactivation 51 Racivir 51 fulminant hepatitis 51 candidate Zenvia 51 inhaled formulations 51 NS4A 51 severe sepsis 51 OTCBB INSV 51 Quinamed R 51 mRCC 51 everolimus tablets 51 Moraxella catarrhalis 51 humanized interleukin 6 51 pemphigus vulgaris 51 Copegus R 51 TG# [003] 51 Cancidas 51 Firazyr 51 relapsing forms 51 semi synthetic lipoglycopeptide 51 thalidomide Thalomid 51 VYVANSE TM lisdexamfetamine 51 Elacytarabine 51 Herpes zoster 51 YONDELIS R 51 echinocandins 51 cytomegalovirus CMV retinitis 51 inhaled corticosteroid ICS 51 ZALBIN TM 51 OTCBB OHRP 51 GI motility disorders 51 Initiates Clinical 51 MDRSP 51 Entereg R 51 Acute myeloid leukemia AML 51 targeted radiotherapeutics 51 homozygous familial hypercholesterolemia 51 AVASTIN 51 Gram negative 51 ALVESCO 51 transcriptase inhibitor NNRTI 51 Primary IGFD 51 Maribavir 51 PDE# inhibitors 51 Acute Exacerbations 51 Aclidinium 51 CEQ# 51 LEVAQUIN 51 Fabry Disease 51 Toxoid 51 sJIA 51 AzaSite TM 51 Rilonacept 51 BARACLUDE ® 51 intravenous iclaprim 51 TKB# 51 dermatologic disorders 51 mGluR5 NAM 51 Tasigna nilotinib 51 neuro inflammatory disorders 51 relapsed MM 51 Phase 2b Clinical Trial 51 investigational oral hepatitis C 51 Federally Funded Gated 51 Aloxi R 51 MKC# 51 NOMID 51 Atripla combines 51 TACI Ig 51 Dificid 51 Staccato alprazolam 51 chronic ITP patients 51 RhuDex 51 aclidinium bromide 51 investigational hepatitis B 51 Oracea TM 51 chronic HCV 51 AzaSite Xtra 51 Elotuzumab 51 pregabalin Lyrica 51 potent bactericidal killing 51 topical antifungal 51 HBeAg negative 51 respiratory syncytial virus RSV 51 include Healive 51 orally inhaled migraine 51 Opterone R 51 pegylated interferon alfa 2a 51 ZEVALIN ® 51 Meets Primary Endpoint 51 tiapamil 51 Tarceva TM 51 Sphingomab TM 51 immunological disorders 51 BEMA Granisetron 51 ezogabine 51 www.ucb group.com 51 product Fentanyl TAIFUN 51 BioMarin develops 51 CAMPATH R 51 Somatuline Depot 51 alvimopan 51 INS# [001] 51 NASDAQ AVNR 51 Glufosfamide 51 HIV distal sensory 51 Zemiva TM 51 Anturol ® 51 investigational pharmacologically unique 51 OMP #R# 51 Epratuzumab 51 PEG PAL PEGylated recombinant 51 rFVIIIFc 51 catheter occlusion 51 Rheumatoid Arthritis RA 51 Cimzia certolizumab pegol 51 Clevudine 51 steroid refractory GvHD 51 ocular inflammatory 51 juvenile idiopathic arthritis JIA 51 aclidinium 51 CYP#A# CYP#D# 51 acute decompensated heart 51 Community Acquired Pneumonia 51 ankylosing spondylitis psoriatic arthritis 51 transthyretin TTR mediated amyloidosis 51 Factor VIIa Factor VIII 51 dirucotide MBP# 51 FDA APPROVES 51 Pruvel 51 investigational oral inhibitor 51 bacterial fungal 51 modified glutathione analog 51 2 methoxyestradiol 51 RECOTHROM R 51 allosteric modulator NAM 51 Pimavanserin 51 GSK# [002] 51 Testosterone MDTS ® 51 Macrolide 51 dermatological indications 51 Inc. Nasdaq AVRX 51 unresectable recurrent 51 Hepatitis C Virus HCV 51 Difimicin 51 maintaining fistula 51 trastuzumab Herceptin R 51 Vfend 51 Severe VOD 51 NovaBay Aganocide compounds 51 PEG PAL 51 gefitinib Iressa 51 DiaKine Therapeutics 51 Manja Bouman CEO 51 ISTODAX 51 FDA Accepts 51 organ transplant rejection 51 either acutely decompensated 51 highly purified pasteurized 51 decompensated liver disease 51 LymphoStat B 51 CYP#A# isoenzyme 51 ANCA associated 51 Allegra Oral Suspension 51 neuraminidase inhibitor 51 SUPPRELIN R LA 51 severe idiopathic Restless 51 sodium benzoate prescription 51 Therapeutic Vaccine 51 LibiGel ® 51 Zavesca R 51 biologic DMARD 51 hepatic impairment 51 Locteron ® 51 non splenectomized 51 REPRONEX ® menotropins 51 VEGFR2 inhibitor 51 included neutropenia anemia 51 NeuroSTAT ® 51 Investigational Treatment 51 evaluating Nexavar 51 pediatric acute lymphoblastic 51 cardiometabolic diseases Glucophage 51 immune idiopathic thrombocytopenic 51 CVBT #B 51 ® bortezomib 51 humanized anti 51 invasive aspergillosis 51 antithrombotic agent 51 TRIOLEX HE# APOPTONE HE# 51 topical calcineurin inhibitors 51 sitagliptin metformin 51 Pradefovir 51 pulmonary arterial hypertension PAH 51 visilizumab 51 YONDELIS 51 relapsed multiple myeloma 51 include Altastaph TM 51 draining enterocutaneous 51 VIAtab TM 51 Nicotine Conjugate Vaccine 51 JAK inhibitor 51 infertility ophthalmology 51 nucleotide polymerase inhibitor 51 erlotinib Tarceva ® 51 Surfactant Replacement Therapies SRT 51 photodisinfection 51 PDE4 inhibitor 51 Clofarabine 51 systemic anaplastic large 51 cancer neuroendocrine tumor 51 occlusion PAO 51 treat hyperphosphatemia 51 R Saizen R 51 ganciclovir 51 Vascugel 51 chronic HBV infection 51 ularitide 51 Nasdaq SGEN 51 S. aureus bacteremia 51 monoclonal antibody conjugated 51 psoriatic arthritis PsA 51 refractory NSCLC 51 eritoran 51 vemurafenib 51 relapsed refractory multiple myeloma 51 Investigational Oral 51 Copegus ribavirin 51 ZALBIN 51 ILUVIEN ® 51 Acute Attacks 51 lipid disorders 51 postherpetic neuralgia 51 CB2 selective receptor agonist 51 venous thromboembolic events 51 Nasdaq ASTM 51 nosocomial pneumonia NP 51 diabetic nephropathy 51 Junovan 51 inhalation aerosol 51 Laquinimod 51 Vancomycin resistant 51 Granted Orphan Drug 51 COLAZAL R 50 Nasdaq NPSP 50 Invasive fungal infections 50 chronic metabolic acidosis